[
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": ">1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "3000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "4000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "6000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "7000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "8000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "9000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    },
    {
        "molecule_name": "compounds of formula (I)",
        "protein_target_name": "GSK 3α",
        "binding_metric": "IC50",
        "value": "10000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment the compounds of formula (I) do not strongly inhibit, or bind to GSK 3α, for example they have an IC50 value against GSK 3α of 1500 nM or greater; such as 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 9,000 or 10,000 nM or greater."
    }
]